8/8/2026
Psyence BioMed focuses on psilocybin and ibogaine supply
The biotech firm aims for vertical integration in psychedelic therapeutics.
Topic archive
nasdaq
2 stories
8/7/2026
Psyence Biomedical unveils strategic plans in new investor presentation
Psyence Biomedical outlines its focus on psychedelic therapeutics for mental health in a recent investor update.